Sumitomo Pharma Co Ltd (STU:DPM)
€ 3.5 0.02 (0.57%) Market Cap: 1.41 Bil Enterprise Value: 3.06 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 63/100

Q2 2021 Sumitomo Dainippon Pharma Co Ltd Earnings Presentation Transcript

Oct 29, 2020 / NTS GMT
Release Date Price: €10.1 (+6.32%)
Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director

Presentation
Oct 29, 2020 / NTS GMT

=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director
* Tatsuya Kimura

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Hiroshi Tanaka
Mizuho Securities Co., Ltd., Research Division - Senior Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shohei Oda
Morgan Stanley, Research Division - Research Associate
* Takashi Akahane
Tokai Tokyo Research Institute Co., Ltd. - Senior Analyst

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot